ORTEXORTEX News
Tracking SWKS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SW
Earnings PreviewSWKS

Skyworks Options Flip Bullish as Shorts Continue Retreat

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 03:56

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Skyworks Solutions goes into Thursday's Q4 print with options traders making their most decisive call-side tilt in months, even as short interest stays elevated at nearly 16% of the free float.

The options shift is the sharpest signal in the data. The put/call ratio fell to 0.89 on Tuesday, more than two standard deviations below its 20-day average of 1.09. That is the lowest defensive reading of the past year, well beneath the 52-week floor of 0.28, and it marks a clean reversal from September when the ratio sat above 1.26 for weeks. Investors are paying for upside exposure, not protection. The move in the lending market reinforces this. Short interest has dropped 22% over the past month, retreating from a peak above 32 million shares in early October to around 23.7 million. Availability is running at 153%, meaning lenders hold roughly 1.5 shares for every one currently borrowed. Cost to borrow is negligible at 0.47%, down 16% on the week. Nothing in the lending market suggests squeeze pressure or fresh bearish conviction.

The bull-and-bear debate on Skyworks centres on one deal and one customer. The Qorvo acquisition closed three months ahead of schedule, bringing what bulls estimate at $500 million or more in annual cost synergies and a broader RF platform spanning 5G Advanced, Wi-Fi, data centres, and automotive. Analyst targets have moved sharply: Morgan Stanley raised to $95 on November 2, UBS raised to $90 on October 29, and Citigroup and Susquehanna both raised to $90 in the weeks before. Only Mizuho remains bearish with an Underperform rating and a $61 target. The bear case rests on a narrower point: Skyworks already lost content in iPhone 17 and expects only modest gains in iPhone 18, leaving the core business hostage to smartphone volume and Apple's supplier decisions. With the EV/EBITDA multiple compressing roughly 7.7 turns over the past 30 days and the PE sitting around 11.9x, valuation has moved in bulls' favour, but the consensus mean target of $80 is now below the current price of $85.40, so the Street's formal numbers have not caught up with the rally.

The institutional picture shows meaningful fresh positioning. FMR LLC filed a 13G on October 7 disclosing a 12.6% stake. Capital World Investors filed on October 6 disclosing 10.1%. T. Rowe Price filed in August at 7.8%. These are as-last-disclosed figures around the 5% threshold, and positions may have changed since filing. Pzena and BlackRock both filed amendments showing reductions, with Pzena trimming from 11.7% to 9.3% and BlackRock from 11.2% to 7.0%. The insider register is cleaner: October 5 trades were grants and tax-withholding transactions tied to the Qorvo close, not open-market conviction buys or sales. The 90-day net value is flat.

The stock held roughly flat on the week at $85.40, against a median decline of 5% across its closest peers. QCOM fell nearly 10% on the week and ON dropped more than 5%. That relative strength, combined with a short position that remains large in absolute terms at nearly 16% of the float, makes the Thursday print's first read on Qorvo integration progress the specific thing to watch.

Stocks in this article

See the live data behind this article on ORTEX.

Open SWKS on ORTEX →

How this article was generated

Generated
4 Nov 2026, 04:19
Data as of
4 Nov 2026, 03:56
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.